Toll-like receptor 9-MyD88 innate immune pathway (TLR9-MyD88 pathway)

The Toll-like receptor 9-MyD88 innate immune pathway is a critical signaling axis that bridges innate and adaptive immunity by detecting pathogen-derived DNA. Toll-like receptor 9 (TLR9) is an endosomal pattern recognition receptor that specifically recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs, which are prevalent in bacterial and viral genomes but rare in mammalian DNA. Upon ligand binding, TLR9 recruits the myeloid differentiation primary response 88 (MyD88) adapter protein, which serves as a scaffold for the assembly of the myddosome complex. This complex triggers a downstream signaling cascade involving IRAK kinases and TRAF6, ultimately activating transcription factors such as NF-κB and IRF7 to induce the production of type I interferons and pro-inflammatory cytokines. This pathway is essential for the activation of plasmacytoid dendritic cells and the subsequent priming of T and B cell responses. Dysregulation of the TLR9-MyD88 axis is implicated in autoimmune diseases like systemic lupus erythematosus, where self-DNA can trigger chronic inflammation. Conversely, pharmacological activation of this pathway using synthetic CpG oligonucleotides is being extensively investigated as a strategy for cancer immunotherapy and as a vaccine adjuvant to enhance anti-tumor and anti-pathogen immunity.

Other names

TLR9-MyD88 signaling axisTLR9-MyD88 pathwayCpG-DNA-TLR9-MyD88 pathwayTLR9-MyD88-IRF7 signaling axis

TLR9 agonists bind to the endosomal receptor, inducing dimerization and recruitment of the MyD88 adapter protein. This triggers a signaling cascade through IRAK kinases and TRAF6, activating NF-κB and IRF7 to drive the expression of type I interferons and pro-inflammatory cytokines.